Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Melphalan and Stem Cell Transplant in Primary Amyloidosis
NCT00002810Phase 2Completed
- Sponsor
- Temple University
- Start
- May 1996
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in AL amyloidosis (AL), multiple myeloma (MM), sponsored by Temple University. Started May 1996; status: completed.
02
Drugs
melphalan
03
Conditions
AL amyloidosis (AL)multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00002810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002810.